Complete regression of retinal neovascularisation after therapy with interferon alfa in Behcet's disease

被引：0
|
作者：
Stuebiger, N
Koetter, I
Zierhut, M
机构：
[1] Univ Tubingen, Hosp Eye, Dept Gen Ophthalmol 1, D-72076 Tubingen, Germany
[2] Univ Tubingen, Hosp Med, Dept Hematol Oncol Rheumatol & Immunol 2, Tubingen, Germany
来源：
BRITISH JOURNAL OF OPHTHALMOLOGY | 2000年 / 84卷 / 12期
关键词：
D O I：
暂无
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
引用
收藏
页码：1437 / 1438
页数：2
相关论文
共 50 条
  • [31] COMPARISON OF THE FUNCTIONAL OUTCOME IN OCULAR ADAMANTIADES-BEHCET'S DISEASE TREATED WITH INTERFERON-ALFA OR CYCLOSPORINE
    Krause, L.
    Koehler, A.
    A, Altenburg
    Zouboulis, C. C.
    Foerster, M. H.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2008, 26 (04) : S39 - S39
  • [32] Human recombinant interferon alfa-2a for the treatment of Behcet's disease with sight threatening posterior or panuveitis
    Kötter, I
    Zierhut, M
    Eckstein, AK
    Vonthein, R
    Ness, T
    Günaydin, I
    Grimbacher, B
    Blaschke, S
    Meyer-Riemann, W
    Peter, HH
    Stübiger, N
    BRITISH JOURNAL OF OPHTHALMOLOGY, 2003, 87 (04) : 423 - 431
  • [33] REVERSIBLE HYPOPITUITARISM AFTER INTERFERON-ALFA THERAPY
    SAKANE, N
    YOSHIDA, T
    YOSHIOKA, K
    UMEKAWA, T
    KONDO, M
    SHIMATSU, A
    LANCET, 1995, 345 (8960): : 1305 - 1305
  • [34] Therapy of ocular manifestations in Behcet's disease (BD) with interferon alpha (IFN alpha)
    Kotter, I
    Eckstein, A
    Zierhut, M
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 1996, 37 (03) : 4755 - 4755
  • [35] The multifocal ERG-system in ocular Behcet's disease for monitoring the interferon-alfa 2a treatment
    Stuebiger, N
    Besch, D
    Deuter, CME
    Zierhut, M
    Koetter, I
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2003, 44 : U417 - U417
  • [36] Regression of Optic Disc Neovascularization in Patients with Behcet's Uveoretinitis After Infliximab Therapy
    Kawaguchi, Tatsushi
    Sugita, Sunao
    Yamada, Yukiko
    Miyanaga, Masaru
    Mochizuki, Manabu
    JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS, 2010, 26 (06) : 627 - 630
  • [37] INTERFERON ALPHA FOR TREATMENT OF UVEITIS IN BEHCET'S DISEASE
    Dubey, Rahul
    Wakefield, Dennis
    McCluskey, Peter
    CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2011, 39 : 39 - 39
  • [38] Multifocal ERG (MERG) changes in patients with ocular Behcet's Disease (BD) during therapy with interferon-alfa 2a (IFNα2a).
    Stuebiger, N
    Koetter, I
    Apfelstedt-Syila, E
    Zrenner, E
    Zierhut, M
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2000, 41 (04) : S782 - S782
  • [39] Remission of posttransplant lymphoproliferative disorder after interferon alfa therapy
    OBrien, S
    Bernert, RA
    Logan, JL
    Lien, YHH
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1997, 8 (09): : 1483 - 1489
  • [40] Behcet's disease and corticosteroid therapy
    Wechsler, B
    Piette, JC
    Godeau, P
    PRESSE MEDICALE, 1999, 28 (33): : 1819 - 1819
12345